empagliflozinlinagliptinmetformin sold brand name trijardy xr drug combination used treatment type combination empagliflozin linagliptin metformin empagliflozinlinagliptinmetformin approved use united states january lessen risk developing ketoacidosis serious condition body produces high levels blood acids called ketones surgery fda approved changes prescribing information inhibitor diabetes medicines recommend stopped temporarily scheduled surgery empagliflozin stopped least three days scheduled symptoms ketoacidosis include nausea vomiting abdominal pain tiredness trouble combination preparation developed marketed boehringer ingelheim pharmaceuticals inc eli lilly drug article relating gastrointestinal system stub help wikipedia expanding ithttpsenwikipediaorgwikiempagliflozinlinagliptinmetformin